A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder Cancer
Public ClinicalTrials.gov record NCT03661320. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy Alone Versus Neoadjuvant Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post- Surgery Therapy With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle- Invasive Bladder Cancer
Study identification
- NCT ID
- NCT03661320
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 855 participants
Conditions and interventions
Interventions
- Cisplatin Drug
- Gemcitabine Drug
- Nivolumab Biological
Drug · Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 5, 2018
- Primary completion
- Feb 15, 2026
- Completion
- Dec 29, 2027
- Last update posted
- Apr 14, 2026
2018 – 2027
United States locations
- U.S. sites
- 26
- U.S. states
- 18
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution - 0022 | Tucson | Arizona | 85711 | — |
| UC Davis Comprehensive Cancer Center | Sacramento | California | 95817 | — |
| Local Institution - 0021 | Littleton | Colorado | 80120-4413 | — |
| Local Institution - 0036 | Pensacola | Florida | 32503 | — |
| Local Institution - 0004 | Tampa | Florida | 33612 | — |
| Local Institution - 0144 | Atlanta | Georgia | 30342 | — |
| Local Institution - 0005 | Chicago | Illinois | 60637 | — |
| Local Institution - 0006 | Peoria | Illinois | 61615 | — |
| Local Institution - 0181 | Columbia | Maryland | 21044 | — |
| Local Institution - 0009 | Boston | Massachusetts | 02114 | — |
| Local Institution - 0166 | Boston | Massachusetts | 02215 | — |
| Local Institution - 0209 | Boston | Massachusetts | 02215 | — |
| Local Institution - 0025 | Minneapolis | Minnesota | 55404 | — |
| Local Institution - 0129 | Minneapolis | Minnesota | 55455 | — |
| Local Institution - 0183 | Omaha | Nebraska | 68130 | — |
| Local Institution - 0001 | Omaha | Nebraska | 68198-6840 | — |
| Local Institution - 0024 | Las Vegas | Nevada | 89169 | — |
| Local Institution - 0029 | Albany | New York | 12208 | — |
| Local Institution - 0069 | Lake Success | New York | 11042 | — |
| Local Institution - 0047 | New York | New York | 10065 | — |
| Local Institution - 0191 | Cleveland | Ohio | 44195 | — |
| Local Institution - 0028 | Tigard | Oregon | 97223 | — |
| Local Institution - 0189 | Charleston | South Carolina | 29425 | — |
| Local Institution - 0007 | Nashville | Tennessee | 37232 | — |
| Local Institution - 0030 | Austin | Texas | 78731 | — |
| Local Institution - 0023 | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 146 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03661320, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 14, 2026 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03661320 live on ClinicalTrials.gov.